Evidence map›Paper›PMID 36853129›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2023

Characterising cause of death among people treated for drug-susceptible TB in India.

S R Cox, C Padmapriyadarsini, V Mave, B Seth, K Thiruvengadam, S Gaikwad, T R Sahasrabudhe, M Sane, J A Tornheim, B M Shrinivasa and 14 more

Abstract readLetter
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

S R CoxJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
C PadmapriyadarsiniIndian Council of Medical Research-National Institute of Research in Tuberculosis, Chennai, India.
V MaveJohns Hopkins University School of Medicine, Baltimore, MD, USA, Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University (BJGMC-JHU) Clinical Research Site, Pune, India, Johns Hopkins India, Pune, India.
B SethJohns Hopkins University School of Medicine, Baltimore, MD, USA.
K ThiruvengadamIndian Council of Medical Research-National Institute of Research in Tuberculosis, Chennai, India.
S GaikwadByramjee Jeejeebhoy Government Medical College and Sassoon General Hospital, Pune, India.
T R SahasrabudheDr D. Y. Patil Medical College, Hospital and Research Centre, Dr D. Y. Patil Vidyapeeth, Pimpri-Chinchwad, India.
M SaneJohns Hopkins India, Pune, India.
J A TornheimJohns Hopkins University School of Medicine, Baltimore, MD, USA.
B M ShrinivasaIndian Council of Medical Research-National Institute of Research in Tuberculosis, Chennai, India.
R LokhandeByramjee Jeejeebhoy Government Medical College and Sassoon General Hospital, Pune, India.
M S BarthwalDr D. Y. Patil Medical College, Hospital and Research Centre, Dr D. Y. Patil Vidyapeeth, Pimpri-Chinchwad, India.
S V B Y ShivakumarJohns Hopkins India, Pune, India.
S KrishnanJohns Hopkins University School of Medicine, Baltimore, MD, USA.
R SanthappanIndian Council of Medical Research-National Institute of Research in Tuberculosis, Chennai, India.
A KinikarByramjee Jeejeebhoy Government Medical College and Sassoon General Hospital, Pune, India.
A L KakraniDr D. Y. Patil Medical College, Hospital and Research Centre, Dr D. Y. Patil Vidyapeeth, Pimpri-Chinchwad, India.
M ParadkarByramjee Jeejeebhoy Government Medical College-Johns Hopkins University (BJGMC-JHU) Clinical Research Site, Pune, India, Johns Hopkins India, Pune, India.
R C BollingerJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
K SekarIndian Council of Medical Research-National Institute of Research in Tuberculosis, Chennai, India.
A N GupteBoston University School of Public Health, Boston, MA, USA.
L E HannaIndian Council of Medical Research-National Institute of Research in Tuberculosis, Chennai, India.
A GuptaJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
J E GolubJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

MULTIDISCIPLINARY TRAINING PROGRAM IN LUNG DISEASEST32HL007534 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Nadia N Hansel, Larissa A. Shimoda · 1985 to 2026
$28.3M
RESEARCH TRAINING IN MICROBIAL DISEASEST32AI007291 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JOEL N BLANKSON, Sara Elizabeth Cosgrove · 1986 to 2026
$9.1M
The Impact of Diabetes on TB treatment outcomesR01AI097494 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GOLUB, JONATHAN E. · 2013 to 2017
$3.0M
Whole Genome Sequencing of Drug Resistant Tuberculosis in India: Genotype-Phenotype Correlation, Clinical Impact of Resistance, and Sequencing Directly from SputumK23AI135102 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TORNHEIM, JEFFREY · 2018 to 2021
$776k
NHLBI NIH HHS T32 HL007534NIAID NIH HHS K23 AI135102NIAID NIH HHS R01 AI097494NIAID NIH HHS T32 AI007291
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cause of DeathTuberculosisHumansIndia

Identifiers

PMID36853129
PMCPMC11609701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.